Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ADITI ANANTH CORREA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1801206065
CMS profile
5387968
Location
HUNTINGTON BEACH, CA

General Payments · PY2019–2025

$556.89

  • Reported across 30 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$281.45

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $281.45 15

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $151.79 10
Lilly USA, LLC $54.66 2
GENZYME CORPORATION $32.15 1
Corcept Therapeutics $26.84 1
Currax Pharmaceuticals LLC $16.01 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $69.28 4
PY2020 $38.12 2
PY2023 $50.28 2
PY2024 $117.76 7
PY2025 $281.45 15

Payment records · PY2025 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2019202020232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Corcept Therapeutics $26.84 11/20/2025 Food and Beverage Undisputed 06/30/2026 1214203573 CMS
Currax Pharmaceuticals LLC $16.01 06/26/2025 Food and Beverage Undisputed 06/30/2026 1242700632 CMS
GENZYME CORPORATION $32.15 11/14/2025 Food and Beverage Undisputed 06/30/2026 1233528961 CMS
Lilly USA, LLC $26.53 03/19/2025 Food and Beverage Undisputed 06/30/2026 1186489057 CMS
Lilly USA, LLC $28.13 06/12/2025 Food and Beverage Undisputed 06/30/2026 1186491019 CMS
Novo Nordisk Inc $10.40 01/15/2025 Food and Beverage Undisputed 06/30/2026 1188870792 CMS
Novo Nordisk Inc $16.86 01/15/2025 Food and Beverage Undisputed 06/30/2026 1189068625 CMS
Novo Nordisk Inc $17.95 02/19/2025 Food and Beverage Undisputed 06/30/2026 1189100911 CMS
Novo Nordisk Inc $12.67 03/26/2025 Food and Beverage Undisputed 06/30/2026 1188653632 CMS
Novo Nordisk Inc $7.96 05/15/2025 Food and Beverage Undisputed 06/30/2026 1188326033 CMS
Novo Nordisk Inc $18.13 06/05/2025 Food and Beverage Undisputed 06/30/2026 1188873179 CMS
Novo Nordisk Inc $19.74 06/05/2025 Food and Beverage Undisputed 06/30/2026 1188960304 CMS
Novo Nordisk Inc $16.67 07/10/2025 Food and Beverage Undisputed 06/30/2026 1188868474 CMS
Novo Nordisk Inc $10.08 08/22/2025 Food and Beverage Undisputed 06/30/2026 1189016533 CMS
Novo Nordisk Inc $21.33 10/30/2025 Food and Beverage Undisputed 06/30/2026 1189118124 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.